nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—ATP4A—gastric juice—pancreatic cancer	0.123	0.81	CbGeAlD
Esomeprazole—CYP2C19—Tamoxifen—pancreatic cancer	0.0632	0.332	CbGbCtD
Esomeprazole—ATP4A—Secretion of Hydrochloric Acid in Parietal Cells—CCKBR—pancreatic cancer	0.0495	0.303	CbGpPWpGaD
Esomeprazole—ATP4A—Secretion of Hydrochloric Acid in Parietal Cells—GAST—pancreatic cancer	0.0425	0.26	CbGpPWpGaD
Esomeprazole—CYP3A4—Tamoxifen—pancreatic cancer	0.0306	0.161	CbGbCtD
Esomeprazole—CYP3A4—Erlotinib—pancreatic cancer	0.026	0.137	CbGbCtD
Esomeprazole—CYP3A4—Irinotecan—pancreatic cancer	0.0235	0.123	CbGbCtD
Esomeprazole—ATP4B—Ion transport by P-type ATPases—FXYD3—pancreatic cancer	0.0228	0.14	CbGpPWpGaD
Esomeprazole—ATP4A—Ion transport by P-type ATPases—FXYD3—pancreatic cancer	0.0203	0.124	CbGpPWpGaD
Esomeprazole—ATP4B—digestive system—pancreatic cancer	0.0172	0.113	CbGeAlD
Esomeprazole—CYP3A4—Docetaxel—pancreatic cancer	0.0172	0.0904	CbGbCtD
Esomeprazole—CYP3A4—Sunitinib—pancreatic cancer	0.0171	0.0899	CbGbCtD
Esomeprazole—CYP3A4—Doxorubicin—pancreatic cancer	0.0128	0.0674	CbGbCtD
Esomeprazole—ATP4B—Ion channel transport—FXYD3—pancreatic cancer	0.00789	0.0483	CbGpPWpGaD
Esomeprazole—ATP4A—digestive system—pancreatic cancer	0.0075	0.0494	CbGeAlD
Esomeprazole—ATP4A—Ion channel transport—FXYD3—pancreatic cancer	0.00703	0.043	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00275	0.0168	CbGpPWpGaD
Esomeprazole—CYP2C19—digestive system—pancreatic cancer	0.00262	0.0173	CbGeAlD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00245	0.015	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00224	0.0137	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.002	0.0122	CbGpPWpGaD
Esomeprazole—CYP3A4—digestive system—pancreatic cancer	0.00155	0.0102	CbGeAlD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000846	0.00518	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000754	0.00461	CbGpPWpGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—APOE—pancreatic cancer	0.000541	0.00331	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.00025	0.00153	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatic cancer	0.00024	0.00147	CbGpPWpGaD
Esomeprazole—Pancytopenia—Doxorubicin—pancreatic cancer	0.000234	0.000473	CcSEcCtD
Esomeprazole—Renal failure—Epirubicin—pancreatic cancer	0.000233	0.000472	CcSEcCtD
Esomeprazole—Asthenia—Irinotecan—pancreatic cancer	0.000233	0.000472	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000233	0.000471	CcSEcCtD
Esomeprazole—Stomatitis—Epirubicin—pancreatic cancer	0.000232	0.000468	CcSEcCtD
Esomeprazole—Jaundice—Epirubicin—pancreatic cancer	0.000232	0.000468	CcSEcCtD
Esomeprazole—Urinary tract infection—Epirubicin—pancreatic cancer	0.000231	0.000467	CcSEcCtD
Esomeprazole—Conjunctivitis—Epirubicin—pancreatic cancer	0.000231	0.000467	CcSEcCtD
Esomeprazole—Dysuria—Doxorubicin—pancreatic cancer	0.00023	0.000466	CcSEcCtD
Esomeprazole—Neutropenia—Doxorubicin—pancreatic cancer	0.00023	0.000466	CcSEcCtD
Esomeprazole—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000229	0.000464	CcSEcCtD
Esomeprazole—Dry mouth—Docetaxel—pancreatic cancer	0.000229	0.000463	CcSEcCtD
Esomeprazole—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000229	0.000463	CcSEcCtD
Esomeprazole—Pollakiuria—Doxorubicin—pancreatic cancer	0.000228	0.000461	CcSEcCtD
Esomeprazole—Asthenia—Gemcitabine—pancreatic cancer	0.000227	0.000459	CcSEcCtD
Esomeprazole—Haematuria—Epirubicin—pancreatic cancer	0.000226	0.000458	CcSEcCtD
Esomeprazole—Confusional state—Docetaxel—pancreatic cancer	0.000226	0.000458	CcSEcCtD
Esomeprazole—Photosensitivity reaction—Doxorubicin—pancreatic cancer	0.000225	0.000455	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Epirubicin—pancreatic cancer	0.000225	0.000454	CcSEcCtD
Esomeprazole—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000225	0.000454	CcSEcCtD
Esomeprazole—Weight increased—Doxorubicin—pancreatic cancer	0.000224	0.000454	CcSEcCtD
Esomeprazole—Epistaxis—Epirubicin—pancreatic cancer	0.000224	0.000453	CcSEcCtD
Esomeprazole—Pruritus—Gemcitabine—pancreatic cancer	0.000224	0.000453	CcSEcCtD
Esomeprazole—Infection—Docetaxel—pancreatic cancer	0.000223	0.000451	CcSEcCtD
Esomeprazole—Weight decreased—Doxorubicin—pancreatic cancer	0.000223	0.000451	CcSEcCtD
Esomeprazole—Sinusitis—Epirubicin—pancreatic cancer	0.000223	0.000451	CcSEcCtD
Esomeprazole—Diarrhoea—Irinotecan—pancreatic cancer	0.000222	0.00045	CcSEcCtD
Esomeprazole—Agranulocytosis—Epirubicin—pancreatic cancer	0.000222	0.000448	CcSEcCtD
Esomeprazole—Shock—Docetaxel—pancreatic cancer	0.000221	0.000447	CcSEcCtD
Esomeprazole—Nervous system disorder—Docetaxel—pancreatic cancer	0.00022	0.000446	CcSEcCtD
Esomeprazole—Pruritus—Fluorouracil—pancreatic cancer	0.00022	0.000445	CcSEcCtD
Esomeprazole—Thrombocytopenia—Docetaxel—pancreatic cancer	0.00022	0.000445	CcSEcCtD
Esomeprazole—Infestation NOS—Doxorubicin—pancreatic cancer	0.00022	0.000445	CcSEcCtD
Esomeprazole—Infestation—Doxorubicin—pancreatic cancer	0.00022	0.000445	CcSEcCtD
Esomeprazole—Tachycardia—Docetaxel—pancreatic cancer	0.000219	0.000443	CcSEcCtD
Esomeprazole—Skin disorder—Docetaxel—pancreatic cancer	0.000218	0.000441	CcSEcCtD
Esomeprazole—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000218	0.000441	CcSEcCtD
Esomeprazole—Bradycardia—Epirubicin—pancreatic cancer	0.000217	0.000439	CcSEcCtD
Esomeprazole—Diarrhoea—Gemcitabine—pancreatic cancer	0.000217	0.000438	CcSEcCtD
Esomeprazole—Renal failure—Doxorubicin—pancreatic cancer	0.000216	0.000437	CcSEcCtD
Esomeprazole—Dizziness—Irinotecan—pancreatic cancer	0.000215	0.000435	CcSEcCtD
Esomeprazole—Jaundice—Doxorubicin—pancreatic cancer	0.000214	0.000433	CcSEcCtD
Esomeprazole—Stomatitis—Doxorubicin—pancreatic cancer	0.000214	0.000433	CcSEcCtD
Esomeprazole—Anorexia—Docetaxel—pancreatic cancer	0.000214	0.000433	CcSEcCtD
Esomeprazole—Rhinitis—Epirubicin—pancreatic cancer	0.000214	0.000432	CcSEcCtD
Esomeprazole—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000214	0.000432	CcSEcCtD
Esomeprazole—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000214	0.000432	CcSEcCtD
Esomeprazole—Hepatitis—Epirubicin—pancreatic cancer	0.000213	0.000431	CcSEcCtD
Esomeprazole—Diarrhoea—Fluorouracil—pancreatic cancer	0.000213	0.000431	CcSEcCtD
Esomeprazole—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000212	0.000429	CcSEcCtD
Esomeprazole—Pharyngitis—Epirubicin—pancreatic cancer	0.000212	0.000428	CcSEcCtD
Esomeprazole—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000211	0.000426	CcSEcCtD
Esomeprazole—Oedema peripheral—Epirubicin—pancreatic cancer	0.00021	0.000425	CcSEcCtD
Esomeprazole—Haematuria—Doxorubicin—pancreatic cancer	0.00021	0.000424	CcSEcCtD
Esomeprazole—Connective tissue disorder—Epirubicin—pancreatic cancer	0.00021	0.000424	CcSEcCtD
Esomeprazole—Urethral disorder—Epirubicin—pancreatic cancer	0.000209	0.000423	CcSEcCtD
Esomeprazole—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.000208	0.00042	CcSEcCtD
Esomeprazole—Epistaxis—Doxorubicin—pancreatic cancer	0.000207	0.000419	CcSEcCtD
Esomeprazole—Vomiting—Irinotecan—pancreatic cancer	0.000207	0.000418	CcSEcCtD
Esomeprazole—Sinusitis—Doxorubicin—pancreatic cancer	0.000206	0.000417	CcSEcCtD
Esomeprazole—Dizziness—Fluorouracil—pancreatic cancer	0.000206	0.000416	CcSEcCtD
Esomeprazole—Visual impairment—Epirubicin—pancreatic cancer	0.000205	0.000416	CcSEcCtD
Esomeprazole—Agranulocytosis—Doxorubicin—pancreatic cancer	0.000205	0.000415	CcSEcCtD
Esomeprazole—Rash—Irinotecan—pancreatic cancer	0.000205	0.000414	CcSEcCtD
Esomeprazole—Dermatitis—Irinotecan—pancreatic cancer	0.000205	0.000414	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000205	0.000414	CcSEcCtD
Esomeprazole—Headache—Irinotecan—pancreatic cancer	0.000204	0.000412	CcSEcCtD
Esomeprazole—Insomnia—Docetaxel—pancreatic cancer	0.000203	0.000411	CcSEcCtD
Esomeprazole—Paraesthesia—Docetaxel—pancreatic cancer	0.000202	0.000408	CcSEcCtD
Esomeprazole—Erythema multiforme—Epirubicin—pancreatic cancer	0.000202	0.000408	CcSEcCtD
Esomeprazole—Vomiting—Gemcitabine—pancreatic cancer	0.000201	0.000407	CcSEcCtD
Esomeprazole—Bradycardia—Doxorubicin—pancreatic cancer	0.000201	0.000406	CcSEcCtD
Esomeprazole—Dyspnoea—Docetaxel—pancreatic cancer	0.0002	0.000405	CcSEcCtD
Esomeprazole—Somnolence—Docetaxel—pancreatic cancer	0.0002	0.000404	CcSEcCtD
Esomeprazole—Rash—Gemcitabine—pancreatic cancer	0.0002	0.000404	CcSEcCtD
Esomeprazole—Dermatitis—Gemcitabine—pancreatic cancer	0.000199	0.000403	CcSEcCtD
Esomeprazole—Eye disorder—Epirubicin—pancreatic cancer	0.000199	0.000403	CcSEcCtD
Esomeprazole—Tinnitus—Epirubicin—pancreatic cancer	0.000199	0.000402	CcSEcCtD
Esomeprazole—Headache—Gemcitabine—pancreatic cancer	0.000198	0.000401	CcSEcCtD
Esomeprazole—Flushing—Epirubicin—pancreatic cancer	0.000198	0.0004	CcSEcCtD
Esomeprazole—Vomiting—Fluorouracil—pancreatic cancer	0.000198	0.0004	CcSEcCtD
Esomeprazole—Rhinitis—Doxorubicin—pancreatic cancer	0.000198	0.0004	CcSEcCtD
Esomeprazole—Dyspepsia—Docetaxel—pancreatic cancer	0.000198	0.0004	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—pancreatic cancer	0.000197	0.000399	CcSEcCtD
Esomeprazole—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000196	0.000397	CcSEcCtD
Esomeprazole—Rash—Fluorouracil—pancreatic cancer	0.000196	0.000397	CcSEcCtD
Esomeprazole—Dermatitis—Fluorouracil—pancreatic cancer	0.000196	0.000396	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—pancreatic cancer	0.000196	0.000396	CcSEcCtD
Esomeprazole—Decreased appetite—Docetaxel—pancreatic cancer	0.000195	0.000395	CcSEcCtD
Esomeprazole—Headache—Fluorouracil—pancreatic cancer	0.000195	0.000394	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000195	0.000394	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000194	0.000393	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000194	0.000392	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000194	0.000392	CcSEcCtD
Esomeprazole—Fatigue—Docetaxel—pancreatic cancer	0.000194	0.000392	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—pancreatic cancer	0.000193	0.000391	CcSEcCtD
Esomeprazole—Nausea—Irinotecan—pancreatic cancer	0.000193	0.00039	CcSEcCtD
Esomeprazole—Immune system disorder—Epirubicin—pancreatic cancer	0.000193	0.00039	CcSEcCtD
Esomeprazole—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000192	0.000389	CcSEcCtD
Esomeprazole—Constipation—Docetaxel—pancreatic cancer	0.000192	0.000388	CcSEcCtD
Esomeprazole—Pain—Docetaxel—pancreatic cancer	0.000192	0.000388	CcSEcCtD
Esomeprazole—Chills—Epirubicin—pancreatic cancer	0.000191	0.000387	CcSEcCtD
Esomeprazole—Visual impairment—Doxorubicin—pancreatic cancer	0.00019	0.000385	CcSEcCtD
Esomeprazole—Alopecia—Epirubicin—pancreatic cancer	0.000188	0.000381	CcSEcCtD
Esomeprazole—Nausea—Gemcitabine—pancreatic cancer	0.000188	0.00038	CcSEcCtD
Esomeprazole—Mental disorder—Epirubicin—pancreatic cancer	0.000187	0.000378	CcSEcCtD
Esomeprazole—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000187	0.000377	CcSEcCtD
Esomeprazole—Malnutrition—Epirubicin—pancreatic cancer	0.000186	0.000375	CcSEcCtD
Esomeprazole—Feeling abnormal—Docetaxel—pancreatic cancer	0.000185	0.000374	CcSEcCtD
Esomeprazole—Nausea—Fluorouracil—pancreatic cancer	0.000185	0.000374	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—pancreatic cancer	0.000184	0.000373	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—pancreatic cancer	0.000184	0.000372	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000184	0.000371	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—pancreatic cancer	0.000183	0.00037	CcSEcCtD
Esomeprazole—Flatulence—Epirubicin—pancreatic cancer	0.000183	0.00037	CcSEcCtD
Esomeprazole—Tension—Epirubicin—pancreatic cancer	0.000182	0.000368	CcSEcCtD
Esomeprazole—Dysgeusia—Epirubicin—pancreatic cancer	0.000182	0.000368	CcSEcCtD
Esomeprazole—Nervousness—Epirubicin—pancreatic cancer	0.00018	0.000365	CcSEcCtD
Esomeprazole—Back pain—Epirubicin—pancreatic cancer	0.00018	0.000363	CcSEcCtD
Esomeprazole—Muscle spasms—Epirubicin—pancreatic cancer	0.000178	0.000361	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—pancreatic cancer	0.000178	0.00036	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000178	0.00036	CcSEcCtD
Esomeprazole—Abdominal pain—Docetaxel—pancreatic cancer	0.000178	0.000359	CcSEcCtD
Esomeprazole—Body temperature increased—Docetaxel—pancreatic cancer	0.000178	0.000359	CcSEcCtD
Esomeprazole—Chills—Doxorubicin—pancreatic cancer	0.000177	0.000358	CcSEcCtD
Esomeprazole—Vision blurred—Epirubicin—pancreatic cancer	0.000175	0.000354	CcSEcCtD
Esomeprazole—Alopecia—Doxorubicin—pancreatic cancer	0.000174	0.000353	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—pancreatic cancer	0.000173	0.00035	CcSEcCtD
Esomeprazole—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000172	0.000348	CcSEcCtD
Esomeprazole—Malnutrition—Doxorubicin—pancreatic cancer	0.000172	0.000347	CcSEcCtD
Esomeprazole—Anaemia—Epirubicin—pancreatic cancer	0.000172	0.000347	CcSEcCtD
Esomeprazole—Agitation—Epirubicin—pancreatic cancer	0.000171	0.000345	CcSEcCtD
Esomeprazole—Flatulence—Doxorubicin—pancreatic cancer	0.000169	0.000342	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—pancreatic cancer	0.000169	0.000341	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—pancreatic cancer	0.000168	0.00034	CcSEcCtD
Esomeprazole—Malaise—Epirubicin—pancreatic cancer	0.000167	0.000339	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—pancreatic cancer	0.000167	0.000337	CcSEcCtD
Esomeprazole—Vertigo—Epirubicin—pancreatic cancer	0.000167	0.000337	CcSEcCtD
Esomeprazole—Leukopenia—Epirubicin—pancreatic cancer	0.000166	0.000336	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—pancreatic cancer	0.000166	0.000336	CcSEcCtD
Esomeprazole—Hypersensitivity—Docetaxel—pancreatic cancer	0.000165	0.000335	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—pancreatic cancer	0.000165	0.000334	CcSEcCtD
Esomeprazole—Palpitations—Epirubicin—pancreatic cancer	0.000164	0.000332	CcSEcCtD
Esomeprazole—Cough—Epirubicin—pancreatic cancer	0.000162	0.000328	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—pancreatic cancer	0.000162	0.000327	CcSEcCtD
Esomeprazole—Asthenia—Docetaxel—pancreatic cancer	0.000161	0.000326	CcSEcCtD
Esomeprazole—Hypertension—Epirubicin—pancreatic cancer	0.00016	0.000324	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000159	0.000322	CcSEcCtD
Esomeprazole—Pruritus—Docetaxel—pancreatic cancer	0.000159	0.000321	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—pancreatic cancer	0.000159	0.000321	CcSEcCtD
Esomeprazole—Chest pain—Epirubicin—pancreatic cancer	0.000158	0.00032	CcSEcCtD
Esomeprazole—Arthralgia—Epirubicin—pancreatic cancer	0.000158	0.00032	CcSEcCtD
Esomeprazole—Myalgia—Epirubicin—pancreatic cancer	0.000158	0.00032	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—pancreatic cancer	0.000158	0.000319	CcSEcCtD
Esomeprazole—Anxiety—Epirubicin—pancreatic cancer	0.000157	0.000319	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000157	0.000317	CcSEcCtD
Esomeprazole—Discomfort—Epirubicin—pancreatic cancer	0.000156	0.000316	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—pancreatic cancer	0.000155	0.000313	CcSEcCtD
Esomeprazole—Dry mouth—Epirubicin—pancreatic cancer	0.000155	0.000313	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—pancreatic cancer	0.000154	0.000312	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—pancreatic cancer	0.000154	0.000311	CcSEcCtD
Esomeprazole—Diarrhoea—Docetaxel—pancreatic cancer	0.000154	0.000311	CcSEcCtD
Esomeprazole—Confusional state—Epirubicin—pancreatic cancer	0.000153	0.000309	CcSEcCtD
Esomeprazole—Palpitations—Doxorubicin—pancreatic cancer	0.000152	0.000307	CcSEcCtD
Esomeprazole—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000151	0.000306	CcSEcCtD
Esomeprazole—Infection—Epirubicin—pancreatic cancer	0.000151	0.000304	CcSEcCtD
Esomeprazole—Cough—Doxorubicin—pancreatic cancer	0.00015	0.000303	CcSEcCtD
Esomeprazole—Shock—Epirubicin—pancreatic cancer	0.000149	0.000301	CcSEcCtD
Esomeprazole—Nervous system disorder—Epirubicin—pancreatic cancer	0.000149	0.0003	CcSEcCtD
Esomeprazole—Dizziness—Docetaxel—pancreatic cancer	0.000149	0.0003	CcSEcCtD
Esomeprazole—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000148	0.0003	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—pancreatic cancer	0.000148	0.0003	CcSEcCtD
Esomeprazole—Tachycardia—Epirubicin—pancreatic cancer	0.000148	0.000299	CcSEcCtD
Esomeprazole—Skin disorder—Epirubicin—pancreatic cancer	0.000147	0.000298	CcSEcCtD
Esomeprazole—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000146	0.000296	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—pancreatic cancer	0.000146	0.000296	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—pancreatic cancer	0.000146	0.000296	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—pancreatic cancer	0.000146	0.000296	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—pancreatic cancer	0.000146	0.000295	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000145	0.000294	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—pancreatic cancer	0.000144	0.000292	CcSEcCtD
Esomeprazole—Anorexia—Epirubicin—pancreatic cancer	0.000144	0.000292	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—pancreatic cancer	0.000143	0.000289	CcSEcCtD
Esomeprazole—Vomiting—Docetaxel—pancreatic cancer	0.000143	0.000289	CcSEcCtD
Esomeprazole—Rash—Docetaxel—pancreatic cancer	0.000142	0.000286	CcSEcCtD
Esomeprazole—Dermatitis—Docetaxel—pancreatic cancer	0.000141	0.000286	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—pancreatic cancer	0.000141	0.000286	CcSEcCtD
Esomeprazole—Headache—Docetaxel—pancreatic cancer	0.000141	0.000285	CcSEcCtD
Esomeprazole—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.00014	0.000284	CcSEcCtD
Esomeprazole—Infection—Doxorubicin—pancreatic cancer	0.000139	0.000282	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000138	0.000279	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—pancreatic cancer	0.000138	0.000279	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000137	0.000278	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000137	0.000278	CcSEcCtD
Esomeprazole—Insomnia—Epirubicin—pancreatic cancer	0.000137	0.000277	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—pancreatic cancer	0.000137	0.000277	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—pancreatic cancer	0.000136	0.000275	CcSEcCtD
Esomeprazole—Paraesthesia—Epirubicin—pancreatic cancer	0.000136	0.000275	CcSEcCtD
Esomeprazole—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000136	0.000274	CcSEcCtD
Esomeprazole—Dyspnoea—Epirubicin—pancreatic cancer	0.000135	0.000273	CcSEcCtD
Esomeprazole—Somnolence—Epirubicin—pancreatic cancer	0.000135	0.000272	CcSEcCtD
Esomeprazole—Anorexia—Doxorubicin—pancreatic cancer	0.000134	0.00027	CcSEcCtD
Esomeprazole—Nausea—Docetaxel—pancreatic cancer	0.000133	0.00027	CcSEcCtD
Esomeprazole—Dyspepsia—Epirubicin—pancreatic cancer	0.000133	0.00027	CcSEcCtD
Esomeprazole—Decreased appetite—Epirubicin—pancreatic cancer	0.000132	0.000266	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000131	0.000265	CcSEcCtD
Esomeprazole—Fatigue—Epirubicin—pancreatic cancer	0.000131	0.000264	CcSEcCtD
Esomeprazole—Pain—Epirubicin—pancreatic cancer	0.00013	0.000262	CcSEcCtD
Esomeprazole—Constipation—Epirubicin—pancreatic cancer	0.00013	0.000262	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000128	0.000258	CcSEcCtD
Esomeprazole—Insomnia—Doxorubicin—pancreatic cancer	0.000127	0.000256	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—pancreatic cancer	0.000126	0.000255	CcSEcCtD
Esomeprazole—Dyspnoea—Doxorubicin—pancreatic cancer	0.000125	0.000253	CcSEcCtD
Esomeprazole—Feeling abnormal—Epirubicin—pancreatic cancer	0.000125	0.000253	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—pancreatic cancer	0.000125	0.000252	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000124	0.000251	CcSEcCtD
Esomeprazole—Dyspepsia—Doxorubicin—pancreatic cancer	0.000123	0.00025	CcSEcCtD
Esomeprazole—Decreased appetite—Doxorubicin—pancreatic cancer	0.000122	0.000246	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000121	0.000245	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—pancreatic cancer	0.000121	0.000244	CcSEcCtD
Esomeprazole—Urticaria—Epirubicin—pancreatic cancer	0.00012	0.000243	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—pancreatic cancer	0.00012	0.000242	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—pancreatic cancer	0.00012	0.000242	CcSEcCtD
Esomeprazole—Body temperature increased—Epirubicin—pancreatic cancer	0.00012	0.000242	CcSEcCtD
Esomeprazole—Abdominal pain—Epirubicin—pancreatic cancer	0.00012	0.000242	CcSEcCtD
Esomeprazole—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000116	0.000234	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000115	0.000232	CcSEcCtD
Esomeprazole—Hypersensitivity—Epirubicin—pancreatic cancer	0.000112	0.000226	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—pancreatic cancer	0.000111	0.000225	CcSEcCtD
Esomeprazole—Abdominal pain—Doxorubicin—pancreatic cancer	0.000111	0.000224	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—pancreatic cancer	0.000111	0.000224	CcSEcCtD
Esomeprazole—Asthenia—Epirubicin—pancreatic cancer	0.000109	0.00022	CcSEcCtD
Esomeprazole—Pruritus—Epirubicin—pancreatic cancer	0.000107	0.000217	CcSEcCtD
Esomeprazole—Diarrhoea—Epirubicin—pancreatic cancer	0.000104	0.00021	CcSEcCtD
Esomeprazole—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000103	0.000209	CcSEcCtD
Esomeprazole—Asthenia—Doxorubicin—pancreatic cancer	0.000101	0.000203	CcSEcCtD
Esomeprazole—Dizziness—Epirubicin—pancreatic cancer	0.0001	0.000203	CcSEcCtD
Esomeprazole—Pruritus—Doxorubicin—pancreatic cancer	9.92e-05	0.000201	CcSEcCtD
Esomeprazole—Vomiting—Epirubicin—pancreatic cancer	9.63e-05	0.000195	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—pancreatic cancer	9.59e-05	0.000194	CcSEcCtD
Esomeprazole—Rash—Epirubicin—pancreatic cancer	9.55e-05	0.000193	CcSEcCtD
Esomeprazole—Dermatitis—Epirubicin—pancreatic cancer	9.54e-05	0.000193	CcSEcCtD
Esomeprazole—Headache—Epirubicin—pancreatic cancer	9.49e-05	0.000192	CcSEcCtD
Esomeprazole—Dizziness—Doxorubicin—pancreatic cancer	9.27e-05	0.000187	CcSEcCtD
Esomeprazole—Nausea—Epirubicin—pancreatic cancer	9e-05	0.000182	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—pancreatic cancer	8.91e-05	0.00018	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—pancreatic cancer	8.84e-05	0.000179	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—pancreatic cancer	8.83e-05	0.000179	CcSEcCtD
Esomeprazole—Headache—Doxorubicin—pancreatic cancer	8.78e-05	0.000178	CcSEcCtD
Esomeprazole—Nausea—Doxorubicin—pancreatic cancer	8.33e-05	0.000168	CcSEcCtD
Esomeprazole—CYP2C19—Metabolism—PRSS1—pancreatic cancer	8e-05	0.00049	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ARG2—pancreatic cancer	6.94e-05	0.000425	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TYMP—pancreatic cancer	6.07e-05	0.000371	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	5e-05	0.000306	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GLP1R—pancreatic cancer	4.89e-05	0.000299	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PRSS1—pancreatic cancer	4.81e-05	0.000295	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—DPYD—pancreatic cancer	4.81e-05	0.000294	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	4.56e-05	0.000279	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	4.52e-05	0.000276	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	4.36e-05	0.000267	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ARG2—pancreatic cancer	4.17e-05	0.000255	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	3.97e-05	0.000243	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TYMP—pancreatic cancer	3.65e-05	0.000223	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CD44—pancreatic cancer	3.53e-05	0.000216	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	3.46e-05	0.000212	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	3.43e-05	0.00021	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GCG—pancreatic cancer	3.39e-05	0.000207	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—STK11—pancreatic cancer	3.19e-05	0.000195	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.99e-05	0.000183	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GLP1R—pancreatic cancer	2.94e-05	0.00018	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—DPYD—pancreatic cancer	2.89e-05	0.000177	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	2.74e-05	0.000168	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TYMS—pancreatic cancer	2.74e-05	0.000168	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOE—pancreatic cancer	2.23e-05	0.000136	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CD44—pancreatic cancer	2.13e-05	0.00013	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.11e-05	0.000129	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GCG—pancreatic cancer	2.04e-05	0.000125	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.01e-05	0.000123	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARG—pancreatic cancer	1.94e-05	0.000119	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—STK11—pancreatic cancer	1.92e-05	0.000117	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	1.77e-05	0.000108	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.65e-05	0.000101	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.54e-05	9.43e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.53e-05	9.35e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOE—pancreatic cancer	1.34e-05	8.2e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.33e-05	8.15e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.21e-05	7.4e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.17e-05	7.14e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.06e-05	6.51e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	9.4e-06	5.75e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	9.27e-06	5.67e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTGS2—pancreatic cancer	9.18e-06	5.62e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTEN—pancreatic cancer	8.01e-06	4.9e-05	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKT1—pancreatic cancer	7.68e-06	4.7e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	5.65e-06	3.46e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKT1—pancreatic cancer	4.62e-06	2.82e-05	CbGpPWpGaD
